Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid
Clinical trial NCT03309657 · COMPLETED
Trial details
- NCT number
- NCT03309657
- Sponsor
- Royal Brisbane and Women's Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2020-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.